The role of plasminogen activator inhibitor 1 (PAI-1) after menopause – the influence of hormonal therapy of this period

Grzegorz Stachowiak; Tomasz Stetkiewicz; Ireneusz Połać; Anna Sobczuk; Sławomir Jędrzejczyk; Tomasz Pertyński

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

6/2005
vol. 4

Send email

Copy url:

abstract:

The role of plasminogen activator inhibitor 1 (PAI-1) after menopause – the influence of hormonal therapy of this period

Grzegorz Stachowiak

,

Tomasz Stetkiewicz

,

Ireneusz Połać

,

Anna Sobczuk

,

Sławomir Jędrzejczyk

,

Tomasz Pertyński

Prz Menopauz 2005; 6: 17-21

Online publish date: 2005/12/28

View full text Get citation

PAI-1 is an important inhibitor in the fibrinolytic system. In this article the connection of this glycoprotein with cardiovascular system, obesity and neoplasms in the group of postmenopausal women has been presented. Increased PAI-1 levels after menopause testify to the impaired fibrinolysis, unfavourably influencing female health status. Whereas estrogens, being administered at this time, advantageously decrease its level, enhancing fibrinolytic potential of serum.

keywords:

The role of plasminogen activator inhibitor 1 (PAI-1) after menopause – the influence of hormonal therapy of this period

Grzegorz Stachowiak , Tomasz Stetkiewicz , Ireneusz Połać , Anna Sobczuk , Sławomir Jędrzejczyk , Tomasz Pertyński

PAI-1, fibrinolysis, hormone therapy, menopause

Grzegorz Stachowiak

,

Tomasz Stetkiewicz

,

Ireneusz Połać

,

Anna Sobczuk

,

Sławomir Jędrzejczyk

,

Tomasz Pertyński